Announcements

Michael G. Combs, CEO and President of CorVel Corp, filed a Form 4 on November 9, 2026, reporting multiple stock option exercises and related share disposals that occurred on November 6, 2026.

CorVel Corp Vice President of Accounting Jennifer Yoss filed a Form 4 on November 9, 2026, disclosing the acquisition of 2,200 non-qualified stock options in CorVel Corp (NASDAQ:CRVL) on November 5, 2026.

Director Charles M. Holley filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of 184.614 shares of Amgen Inc. common stock through a restricted stock unit grant at no cost.

Ned N. Fleming III, a director and 10% owner of Construction Partners, Inc. (NASDAQ:ROAD), filed a Form 4 on November 9, 2026, disclosing a privately negotiated purchase of 250 shares of Class B common stock at $88.33 per share on November 9, 2026.

Director Omar Ishrak filed a Form 4 with the SEC on November 7, 2026, reporting the acquisition of 152.0351 shares of Amgen Inc. common stock on November 6, 2026, through a vested Restricted Stock Unit grant at no cost.

ADAR1 Capital Management, LLC and Daniel Schneeberger filed a Form 4 on November 9, 2026, disclosing a purchase of 2,640 common shares of InMed Pharmaceuticals Inc. (now Mentari Therapeutics, Inc.) on November 5, 2026, at a weighted average price of $13.0953 per share.

Karat Packaging Inc. Chief Financial Officer and Director Guo Jian filed a Form 4 on November 9, 2026, disclosing a purchase of 162 shares of common stock through a custodial account established under the Uniform Transfer to Minors Act.